文献速递消化内镜肝病

抗移位全覆膜金属支架治疗肝移植术后吻合口胆管狭窄的临床疗效:传统支架与抗移位支架的比较

Clinical efficacy of anti-migration features in fully covered metallic stents for anastomotic biliary strictures after liver transplantation: comparison of conventional and anti-migration stents.
PubMed 文献 · Gastrointest Endosc · 2018-07-10

该回顾性研究纳入75例肝移植术后吻合口胆管狭窄患者,比较抗移位全覆膜金属支架(Am-FCSEMS)与传统全覆膜金属支架(Std-FCSEMS)的移位率、狭窄缓解率及复发率。结果显示Am-FCSEMS完全移位率更低(1.7% vs 28%,P<.0001),狭窄缓解率更高(93% vs 66.2%,P<.001),随访期间狭窄复发率更低(12.3% vs 55.9%,P<.0001)。

要点

  • Am-FCSEMS完全移位率1.7%(1/57)显著低于Std-FCSEMS的28%(19/68)(P<.0001)。
  • 首次随访ERCP狭窄缓解率Am-FCSEMS为93%(53/57),Std-FCSEMS为66.2%(45/68)(P<.001)。
  • 中位随访28个月后,Am-FCSEMS狭窄复发率12.3%,Std-FCSEMS为55.9%(P<.0001)。

核心结论

  • 在肝移植术后吻合口胆管狭窄患者中,使用Am-FCSEMS可显著降低支架移位风险、提高取支架时的狭窄缓解率并降低随访期间狭窄复发率。
  • 标准支架与抗移位支架的内镜下取出成功率和操作相关并发症相似。

研究设计与样本

  • 回顾性分析两个前瞻性维护数据库(肝移植患者数据库和ERCP及支架置入数据库)中肝移植术后吻合口胆管狭窄接受全覆膜金属支架治疗的患者亚组。
  • 2009年1月至2016年1月期间,连续纳入因肝移植术后吻合口胆管狭窄转诊至Cochin医院(法国巴黎)接受ERCP并置入全覆膜金属支架的患者。
  • 排除标准为其他原因导致的胆管狭窄(如恶性狭窄、缺血性原因)和胆瘘。
  • 共75例患者置入125枚全覆膜金属支架(Am-FCSEMS 57枚,1型Std-FCSEMS 52枚,2型Std-FCSEMS 16枚),所有患者计划支架置入期为6个月。

主要发现

  • 全覆膜金属支架完全移位率为16%(20/125),其中Am-FCSEMS为1.7%(1/57),1型和2型Std-FCSEMS合计为28%(19/68)(P<.0001)。
  • 所有尝试的支架取出(100%患者)均成功。
  • 每枚支架置入后首次随访ERCP显示狭窄缓解率为78.4%(98/125),其中Am-FCSEMS为93%(53/57),1型和2型Std-FCSEMS合计为66.2%(45/68)(P<.001)。
  • 支架取出后中位随访28个月(范围12-66个月),Am-FCSEMS治疗患者狭窄复发率为12.3%(范围11%-17%),Std-FCSEMS治疗患者为55.9%(范围54%-56%)(P<.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Anastomotic biliary strictures (ABSs) are one of the most frequent adverse events that occur after orthotopic liver transplantation (OLT). Multiple plastic stents (MPS) have been validated for this indication. More recently, fully covered self-expandable metallic stents (FCSEMSs) have been used with positive outcomes, but also have a higher rate of migration, which may limit success. Our primary objective was to compare stent migration rates observed with standard FCSEMSs (Std-FCSEMSs) and so-called anti-migration FCSEMSs (Am-FCSEMSs), which are newly designed with reversed proximal side flaps. Secondary objectives were to compare rates of stricture resolution and procedure-related morbidity. METHODS: We conducted a retrospective analysis of a subset of patients (FCSEMSs for post-OLT ABS) from 2 prospectively maintained databases of (1) OLT patients, and (2) ERCP and stent placement. Between January 2009 and January 2016, consecutive patients presenting with ABS after OLT referred to Cochin Hospital (Paris, France) for ERCP and receiving a FCSEMS were included. Exclusion criteria were any other cause of biliary stricture (ie, malignant stricture, ischemic origin), and biliary fistulae. RESULTS: One hundred twenty-five FCSEMSs (57 Am-FCSEMSs, 52 type 1 Std-FCSEMSs, and 16 type 2 Std-FCSEMSs) were used in 75 patients for ABS after OLT, with a planned stent placement period of 6 months in all patients. Patient characteristics and rates of previous endoscopic treatment or timing of ABS occurrence after OLT were not different between the groups. The rate of FCSEMS complete migration was 16% (20/125), consisting of 1.7% (1/57) for Am-FCSEMSs and 28% (19/68) for type 1 and 2 Std-FCSEMSs (P < .0001). All attempted stent removals (100% of patients) were successful. First follow-up ERCP after each FCSEMS highlighted a stricture resolution rate of 78.4% (98/125), including 93% (53/57) for Am-FCSEMSs and 66.2% (45/68) for type 1 and 2 Std-FCSEMSs (P < .001). After a median follow-up of 28 months after stent removal (range, 12-66 months), stricture recurrence was observed in 12.3% (range, 11%-17%) of patients treated with Am-FCSEMSs against 55.9% (range, 54%-56%) of those receiving Std-FCSEMSs (P < .0001). CONCLUSIONS: In patients with ABS after OLT, the use of Am-FCSEMSs significantly decreased the risk of stent migration, improved stricture resolution at the time of stent removal, and reduced the rate of stricture recurrence during follow-up. Endoscopic removal success and procedure-related morbidity were similar for both standard and anti-migration stents.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bordaçahar B, Perdigao F, Leblanc S, et al. Clinical efficacy of anti-migration features in fully covered metallic stents for anastomotic biliary strictures after liver transplantation: comparison of conventional and anti-migration stents. Gastrointest Endosc. 2018. PMID: 30003877. doi:10.1016/j.gie.2018.06.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。